Regulations.gov document

Determination of Regulatory Review Period for Purposes of Patent Extension; DAXXIFY

Notice · FDA-2023-E-3109 · posted Jul 5, 2024

Key facts

Document ID FDA-2023-E-3109-0006
Title Determination of Regulatory Review Period for Purposes of Patent Extension; DAXXIFY
Document type Notice
Subtype Determinations
Agency FDA
Docket FDA-2023-E-3109
Posted Jul 5, 2024
Federal Register citation 89 FR 55597
FR document number 2024-14732
Comment period opens Jul 5, 2024
Comments due Sep 4, 2024
Effective date Jul 5, 2024

At a glance

  • 1–9 Pages
  • No Open for comment
  • None Public comments on this docket

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Regulations.gov documents

Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.

Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date:

Browse all Regulations.gov documents